
Docomed Pharma Private Limited
About Docomed Pharma Private Limited
Data last updated:
Docomed Pharma Private Limited is a private limited company based in Delhi, India. It operates in the diversified business activities segment of the business services sector. It was incorporated on 05 April 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2017PTC315560. Its GSTIN is 07AAGCD1121J2ZZ (Delhi). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prabhat Singh and Aarti Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 56 II Floor Okhla Industrial Area Phase 1, Delhi, India – 110020.
As per the financials filed for FY 2024, the company reported a revenue of ₹36.83 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹62,070 (net margin 1.7%) and EBITDA of ₹2.92 Lakh (EBITDA margin 7.9%). Revenue has grown at a compounded annual rate (CAGR) of 127% over three years and 49% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Docomed Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressB – 56 II Floor Okhla Industrial Area Phase 1, Delhi, India – 110020
- IndustryBusiness Services, Miscellaneous Business Activities, Other Services
To see the full contact details of Docomed Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Docomed Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Docomed Pharma Private Limited, buy the company report.
Financials of Docomed Pharma Private Limited
FY 2025 filings availableDocomed Pharma Private Limited reported revenue of ₹36.83 Lakh (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 49%. EBITDA rose 137% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹62,070 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.9% | ||||
| Net Profit Margin | 1.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Docomed Pharma Private Limited, buy the company report.
Board of directors of Docomed Pharma Private Limited
Docomed Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabhat Singh | Director | 22 Jun 2020 | 6 Years 4 Months | Current |
| Aarti Kumari | Director | 22 Jun 2020 | 6 Years 4 Months | Current |
Peer comparison
Docomed Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Mithra's Chamravattom Private Limited | ₹36.85 Lakh (FY 2024) | 57.0% | Malappuram, Kerala, India | |||
| Svnova Remedies Private Limited | ₹36.84 Lakh (FY 2022) | -29.0% | Bangalore, Karnataka, India | |||
| Athina Marine Services Private Limited | ₹36.84 Lakh (FY 2025) | -7.0% | Gurugram, Haryana, India | |||
| Nath Dware Commerce Private Limited | ₹36.84 Lakh (FY 2016) | -4.0% | Delhi, India | |||
| Medico Exim Private Limited | ₹36.84 Lakh (FY 2022) | -70.0% | Ahmedabad, Gujarat, India | |||
| Docomed Pharma Private Limitedthis company | ₹36.83 Lakh (FY 2024) | ₹62,070 | 1.7% | -1.0% | Delhi, India | |
| Right Air Products Private Limited | ₹36.83 Lakh (FY 2025) | 46.0% | Panvel, Maharashtra, India | |||
| House of Engineering & Solutions Private Limited | ₹36.83 Lakh (FY 2021) | Ghaziabad, Uttar Pradesh, India | ||||
| Regrow Manpower Solutions Private Limited | ₹36.82 Lakh (FY 2023) | 893.0% | Delhi, India | |||
| 9 Elements Holdings Private Limited | ₹36.82 Lakh (FY 2023) | 2.0% | Surat, Gujarat, India | |||
| Publicidad Digital Private Limited | ₹36.81 Lakh (FY 2025) | -38.0% | Rajgangpur, Odisha, India |
To see the full peer comparison of Docomed Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Docomed Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Docomed Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Docomed Pharma has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAGCD1121J2ZZ | Delhi | Active | 03 Sep 2020 |
To see the full GST registrations and return filing status of Docomed Pharma Private Limited, buy the company report.
Recent activity
Docomed Pharma Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Mukesh Chaudhary ceased to be Director on 29 Jun 2020.
Frequently asked questions
Docomed Pharma is an active private limited company based in Delhi, India. The company works in miscellaneous business activities, within the business services industry. It was incorporated on 05 April 2017 (9+ years old) and is registered under CIN U74999DL2017PTC315560.
Docomed Pharma has 2 current directors:
- Prabhat Singh - Director
- Aarti Kumari - Director
The latest financial statements of Docomed Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Docomed Pharma is 07AAGCD1121J2ZZ, registered in Delhi. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Docomed Pharma is U74999DL2017PTC315560. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Docomed Pharma was incorporated on 05 April 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Docomed Pharma by revenue are Mithra's Chamravattom Private Limited, Svnova Remedies Private Limited, Athina Marine Services Private Limited, Nath Dware Commerce Private Limited, Medico Exim Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Mukesh Chaudhary ceased to be Director on 29 Jun 2020. Rohit Kumar ceased to be Director on 29 Jun 2020. Aarti Kumari was appointed as Director on 22 Jun 2020. Docomed Pharma has 4 board changes on record in total.
The registered office of Docomed Pharma is at B – 56 II Floor Okhla Industrial Area Phase 1, Delhi, India – 110020.
Docomed Pharma operates in the business services industry, in the miscellaneous business activities segment.
The compliance status of Docomed Pharma is compliant as of 10 September 2026. The company is actively filing with the Registrar of Companies.

